NO20025069L - Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme - Google Patents

Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme

Info

Publication number
NO20025069L
NO20025069L NO20025069A NO20025069A NO20025069L NO 20025069 L NO20025069 L NO 20025069L NO 20025069 A NO20025069 A NO 20025069A NO 20025069 A NO20025069 A NO 20025069A NO 20025069 L NO20025069 L NO 20025069L
Authority
NO
Norway
Prior art keywords
preparing
same
stable crystal
new stable
thiazolidinedione derivative
Prior art date
Application number
NO20025069A
Other languages
English (en)
Other versions
NO20025069D0 (no
Inventor
Michiro Ohnota
Kazuo Orita
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of NO20025069L publication Critical patent/NO20025069L/no
Publication of NO20025069D0 publication Critical patent/NO20025069D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20025069A 2000-04-25 2002-10-22 Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme NO20025069D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000124006 2000-04-25
PCT/JP2001/003450 WO2001081327A1 (fr) 2000-04-25 2001-04-23 Nouveau cristal stable de derive thiazolidinedione et son procede de production

Publications (2)

Publication Number Publication Date
NO20025069L true NO20025069L (no) 2002-10-22
NO20025069D0 NO20025069D0 (no) 2002-10-22

Family

ID=18634205

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025069A NO20025069D0 (no) 2000-04-25 2002-10-22 Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme

Country Status (23)

Country Link
US (1) US6770133B2 (no)
EP (1) EP1277745A4 (no)
KR (1) KR20030007548A (no)
CN (1) CN1426402A (no)
AU (1) AU4882801A (no)
BG (1) BG107200A (no)
BR (1) BR0110258A (no)
CA (1) CA2407349A1 (no)
CZ (1) CZ20023502A3 (no)
EA (1) EA004244B1 (no)
EE (1) EE200200601A (no)
HK (1) HK1053835A1 (no)
HU (1) HUP0300475A3 (no)
IL (1) IL152224A0 (no)
IS (1) IS6586A (no)
MA (1) MA25664A1 (no)
MX (1) MXPA02010545A (no)
NO (1) NO20025069D0 (no)
PL (1) PL365533A1 (no)
SK (1) SK15142002A3 (no)
WO (1) WO2001081327A1 (no)
YU (1) YU80302A (no)
ZA (1) ZA200208293B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1253145B1 (en) * 2000-02-01 2006-09-20 Kyorin Pharmaceutical Co., Ltd. Alkali metal salt of thiazolidine-2,4-dione derivatives
JPWO2003062214A1 (ja) * 2002-01-23 2005-05-19 杏林製薬株式会社 ベンジルチアゾリジンジオン誘導体の新規な安定結晶とその製法
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
KR20060109926A (ko) 2003-11-19 2006-10-23 메타베이시스 테라퓨틱스, 인크. 새로운 인-함유 갑상선 호르몬 모방약들
DE602004004631D1 (de) 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
TWI383008B (zh) * 2005-08-17 2013-01-21 Nippon Catalytic Chem Ind 吸水性樹脂之製造方法及吸水性樹脂以及其利用
TW201336497A (zh) 2007-02-08 2013-09-16 Daiichi Sankyo Co Ltd 噻唑啶二酮化合物之結晶型及其製法
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864028A (en) * 1983-09-14 1989-09-05 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JPH04270273A (ja) 1991-02-25 1992-09-25 Kyorin Pharmaceut Co Ltd チアゾリジン−2,4−ジオン誘導体とその塩及びその製造法
JP3053490B2 (ja) 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
JP3644998B2 (ja) * 1995-02-09 2005-05-11 塩野義製薬株式会社 ベンジリデン誘導体の結晶の選択的取得方法
US6147101A (en) * 1995-06-02 2000-11-14 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
US6001862A (en) * 1995-06-02 1999-12-14 Kyorin Pharameuticals Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JPH101476A (ja) * 1996-02-28 1998-01-06 Nissan Chem Ind Ltd 効力が向上したチフルザミド
ZA971637B (en) * 1996-02-28 1997-09-25 Nissan Chemical Ind Ltd Thifluzamide with improved efficacy.
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
IL152224A0 (en) 2003-05-29
MA25664A1 (fr) 2002-12-31
SK15142002A3 (sk) 2003-04-01
WO2001081327A1 (fr) 2001-11-01
CA2407349A1 (en) 2002-10-24
AU4882801A (en) 2001-11-07
CN1426402A (zh) 2003-06-25
HK1053835A1 (zh) 2003-11-07
EP1277745A4 (en) 2004-09-15
IS6586A (is) 2002-10-21
ZA200208293B (en) 2003-10-06
US20030101925A1 (en) 2003-06-05
BG107200A (bg) 2003-11-28
EA004244B1 (ru) 2004-02-26
PL365533A1 (en) 2005-01-10
HUP0300475A3 (en) 2004-10-28
HUP0300475A2 (hu) 2003-06-28
YU80302A (sh) 2005-11-28
US6770133B2 (en) 2004-08-03
MXPA02010545A (es) 2004-05-14
BR0110258A (pt) 2003-01-07
CZ20023502A3 (cs) 2003-06-18
NO20025069D0 (no) 2002-10-22
EE200200601A (et) 2004-04-15
KR20030007548A (ko) 2003-01-23
EA200201055A1 (ru) 2003-06-26
EP1277745A1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
NO20030844D0 (no) Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
NO20032726D0 (no) Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav
NO20024623L (no) Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
NO20025069D0 (no) Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme
DK1383733T3 (da) Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser
NO20026013D0 (no) Medisinske preparater inneholdende propenonderivater
NO20031319D0 (no) Fremgangsmåte for fremstilling av N-(substituert fenyl)-3- alkyl-, aryl- ogheteroaryl-sulfonyl-2-hydroksy-2-alkyl- oghalogenalkylpropanamidforbindelser
NO20021124D0 (no) Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor
NO20033506L (no) Parasitticidale preparater og metoder for anvendelse
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
NO994209D0 (no) FremgangsmÕte for fremstilling av 2-[[(2-pyridinyl)metyl]sulfinyl]-1H-benzimidazoler og nye forbindelser til anvendelse for dette formÕl
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20012099L (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- karbinoler og beslektede forbindelser
NO20023577L (no) Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider
NO20014393D0 (no) 1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse
NO20024887D0 (no) Fremgangsmåte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20042022L (no) Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen
NO20014077L (no) Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid
NO20040346L (no) Ny krystall av aryletensulfonamid-derivat og fremstillingsprosess derav
NO20030587D0 (no) Fremgangsmåte til fremstilling av diskodermolid og analoger derav
NO20032297L (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20031045L (no) Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme
NO990226D0 (no) 1-Isotiazolidinon-derivater av azetidin-2-on, fremgangsmÕter for fremstilling og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application